Synthesis, Analgesic, and Antiparkinsonian Profiles
723
6 h. The obtained residue was solidified with methanol, filtered
off, and crystallized to give 0.1 g (55%) 13. The product was
identified by its mp and Rf value in comparison with an au-
thentic sample. Mp 133–135ꢁC (EtOH=pet. ether]; IR (film):
solid formed was filtered off and crystallized to give 0.24 g
(68%) 18, 0.29 g (82%) 19, and 0.27g (80%) 20.
3-(6-p-Methoxyphenyl-2,3-dihydro-6H-thiazino[3,2-a]pyrimidin-4-
one-8-yl)pyridine (18, C19H17N3O2S)
1
ꢂꢀ¼ 3380–3342 (NH), 1610 (C¼N) cmꢂ1; H NMR (DMSO-
Mp 235–237ꢁC (AcOH=H2O); IR (film): ꢂꢀ¼ 1725 (C¼O)
cmꢂ1; 1H NMR (DMSO-d6): ꢃ ¼ 3.40–3.55 (m, 2CH2 thiazine
ring), 3.64 (s, OCH3), 5.36 (d, H-a, pyrimidine), 6.72–7.15
(m, Ar-Hþ H-b pyrimidine), 7.79–8.48 (m, pyrid-4,5,6), 8.84
(s, pyrid-2) ppm; MS (EI, 70eV): m=z (%) ¼ 351 [Mþ, 12],
166 [100, base peak].
d6): ꢃ ¼ 7.15–7.65 (m, Ar-H), 7.75–8.55 (m, pyrid-4,5,6), 8.76
(s, pyrid-2), 8.62 (s, NH-imidazole, exchangeable with D2O)
ppm; MS (EI, 70eV): m=z (%) ¼ 195 [Mþ, 100, base peak].
Substituted Pyrimidines 15–17
General Procedure
Diamino compounds, namely, guanidine hydrochloride, urea,
and thiourea (1mmol) were added to 0.24 g 2 (1mmol) in
100 cm3 ethanolic potassium hydroxide (1%). The reaction
mixture was refluxed for 4–6 h and then poured gradually with
stirring into cold water. The solid formed was filtered off,
washed with H2O, and crystallized to give 15–17.
7-(Pyridin-3-yl)-5-(p-methoxyphenyl)-2,3-dihydro-5H-3-
methylthiazolo[3,2-a]pyrimidine (19, C19H17N3O2S)
Mp 224–246ꢁC (DMF=H2O); IR (film): ꢂꢀ¼ 1705 (C¼O)
1
cmꢂ1; H NMR (DMSO-d6): ꢃ ¼ 1.36 (s, 3H, CH3), 3.55 (m,
1H, thiazole), 3.64 (s, OCH3), 5.45 (d, H-a, pyrimidine), 6.82–
7.18 (m, Ar-Hþ H-b pyrimidine), 7.84–8.65 (m, pyrid-4,5,6),
8.82 (s, pyrid-2) ppm; MS (EI, 70eV): m=z (%) ¼ 351 [Mþ,
10], 152 [100, base peak].
2-Amino-6-(pyridin-3-yl)-3,4-dihydro-4-(p-methoxyphenyl)
pyrimidine (15, C16H16N4O)
Yield 0.19 g (68%); mp 240–242ꢁC (AcOH=H2O); IR (film):
7-(Pyridin-3-yl)-5-(p-methoxyphenyl)-2,3-dihydro-5H-thiazolo[3,2-
a]pyrimidine (20, C18H15N3O2S)
ꢂꢀ¼ 3440–3320 (NH, NH2) cmꢂ1
;
1H NMR (DMSO-d6):
ꢃ ¼ 3.62 (s, OCH3), 4.55 (s, NH-pyrimidine, exchangeable
with D2O), 5.15 (d, H-a, pyrimidine), 6.75–7.25 (m, Ar-
H þ H-b pyrimidine), 6.60 (bs, NH2, exchangeable with D2O),
7.76–8.45 (m, pyrid-4,5,6), 8.74 (s, pyrid-2) ppm; MS (EI,
70eV): m=z (%) ¼ 280 [Mþ, 15], and at 233 [100, base peak].
Mp 210–212ꢁC (AcOH=H2O); IR (film): ꢂꢀ¼ 1712 (C¼O)
cmꢂ1
;
1H NMR (DMSO-d6): ꢃ ¼ 3.66 (s, OCH3), 3.74 (s,
CH2-thiazole), 5.24 (d, H-a, pyrimidine), 6.80–7.15 (m, Ar-
H þ H-b pyrimidine), 7.78–8.52 (m, pyrid-4,5,6), 8.81 (s,
pyrid-2) ppm; MS (EI, 70eV): m=z (%) ¼ 337 [Mþ, 5], 152
[100, base peak].
6-(Pyridin-3-yl)-1,2,3,4-tetrahydro-2-oxo-4-(p-methoxyphenyl)
pyrimidine (16, C16H15N3O2)
7-(Pyridin-3-yl)-2-(indolylmethylene)-5-(p-methoxyphenyl)-
2,3-dihydro-5-thiazolo[3,2-a]pyrimidine (21, C27H20N4O2S)
Method A: A mixture of 0.297 g 17 (1mmol), 0.094g chloro-
acetic acid (1mmol), 1.5g anhydrous sodium acetate in
40cm3 of a mixture of AcOH=Ac2O (1=3) and 0.145g indole-
3-carboxaldehyde (1mmol) was refluxed for 6 h. The reaction
mixture was cooled and poured into ice-water, the obtained
solid was collected by filtration and crystallized to give 0.39 g
(84%) 21. Mp 232–234ꢁC (EtOH=H2O); IR (film): ꢂꢀ¼ 3355–
Yield 0.18 (66%); mp 246–248ꢁC (DMF=H2O); IR (film):
1
ꢂꢀ¼ 3348–3265 (NH), 1668 (C¼O) cmꢂ1; H NMR (DMSO-
d6): ꢃ ¼ 3.66 (s, OCH3), 5.35 (d, H-a, pyrimidine), 6.80–7.20
(m, Ar-Hþ H-b pyrimidine), 7.86–8.64 (m, pyrid-4,5,6), 8.30
and 8.55 (2s, 2NH-pyrimidine, exchangeable with D2O), 8.78
(s, pyrid-2) ppm; MS (EI, 70 eV): m=z (%) ¼ 281 [Mþ, 100,
base peak].
6-(Pyridin-3-yl)-1,2,3,4-tetrahydro-2-thioxo-4-(p-methoxyphenyl)
pyrimidine (17, C16H15N3OS)
3325 (NH), 1716 (C¼O) cmꢂ1
;
1H NMR (DMSO-d6):
ꢃ ¼ 3.64 (s, OCH3), 5.55 (d, H-a, pyrimidine ring), 6.70–
7.45 (m, indole-Hþ H-b pyrimidine ringþ Ar-Hþ benzylic
proton), 7.80–8.45 (m, pyrid-4,5,6), 8.72 (s, pyrid-2), 9.68
(s, NH-indole, exchangeable with D2O) ppm; 13C NMR
(DMSO-d6): ꢃ ¼ 45.05 (C-a), 55.86 (OCH3), 119.65 (C-b),
110.15, 111.35, 118.10, 119.22, 121.34, 122.94, 126.15,
135.80 (indole-C), 113.65, 127.12, 134.67, 157.26 (Ph-C),
141.10, 162.20 (pyrimidine-C), 141.38 (CH-benzylic-C),
120.85 (thiazole-C), 122.86, 126.32, 130.12, 149.58, 150.81
(pyridine-C), 165.65 (C¼O) ppm; MS (EI, 70eV): m=z (%) ¼
464 [Mþ, 100, base peak].
Yield 0.23 (79%); mp >250ꢁC (AcOH=H2O); IR (film):
1
ꢂꢀ¼ 3368–3255 (NH), 1665 (C¼O), 1215 (C¼S) cmꢂ1; H
NMR (DMSO-d6): ꢃ ¼ 3.63 (s, OCH3), 5.18 (d, H-a, pyrimi-
dine), 6.85–7.26 (m, Ar-Hþ H-b pyrimidine), 7.82–8.46 (m,
pyrid-4,5,6), 8.28 and 8.45 (2s, 2NH-pyrimidine, exchange-
able with D2O), 8.76 (s, pyrid-2) ppm; MS (EI, 70eV): m=z
(%) ¼ 297 [Mþ, 5], and at 112 [100, base peak].
Thiazino- and Thiazolopyrimidines 18–20
General Procedure
Method B: A mixture of 0.337 g 20 (1mmol) and 0.145g
indole-3-carboxaldehyde (1mmol) in 40 cm3 of a mixture of
AcOH=Ac2O (1=3) was refluxed for 5 h, allowed to cool, then
poured into water, and the solid formed was collected by
filtration and crystallized to yield 0.33g (72%) 21, as identi-
fied by its m.p., mixed m.p., and Rf value on TLC by compar-
ison with an authentic sample from method A.
A mixture of 0.297 g 17 (1mmol) and halo compounds,
namely 3-bromopropionic acid, 2-bromopropionic acid, and
chloroacetic acid (1mmol), was dissolved in 40cm3 of a mix-
ture of AcOH=Ac2O (1=3) in the presence 3 g anhydrous
sodium acetate and then refluxed for 6–7 h. The reaction mix-
ture was cooled and poured into cold water with stirring, the